E
Zentalis Pharmaceuticals, Inc. ZNTL
$1.77 -$0.04-2.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 27.68% 21.55% 115.93% -10.82% -2.07%
Total Depreciation and Amortization -7.76% -4.94% -10.00% -6.13% -7.20%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -74.01% 1.68% -361.78% -26.97% 4.80%
Change in Net Operating Assets -251.87% 373.02% -305.70% 157.80% -50.37%
Cash from Operations -13.91% 55.67% -5.46% -8.76% -16.46%
Capital Expenditure 100.00% 43.26% -- -8.13% 94.52%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 141.11% -52.76% 46.21% -256.97% -641.38%
Cash from Investing 141.08% -52.71% 46.11% -253.62% -686.73%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -70.23% -100.00% -33.51% -100.00% -47.54%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -70.23% -100.00% -98.12% -100.00% -47.54%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 102.75% -100.28% 241.08% -16,057.34% -1,137.35%
Weiss Ratings